Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis

References

• Shin S, Song H, Oh S-K, et al. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2013;36(11):1000–1005.
   PubMed Web of Science ®Google Scholar
• Dragomir A, Côté R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Medical Care. 2010;48:418–425.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–618.
   PubMed Web of Science ®Google Scholar
• Mennini FS, Marcellusi A, Schulenburg J., et al. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2015;16(1):65–72.
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to long-term therapies: evidence for action [Internet] [cited 2018 Dec 14]. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1.
   Google Scholar
• Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Kronish IM, Woodward M, Sergie Z, et al. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611–1621.
   PubMed Web of Science ®Google Scholar
• Ewen S, Meyer MR, Cremers B, et al. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Clin Res Cardiol. 2015;104(12):1097–1105.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Ott C, Schmid A, et al. Adherence to antihypertensive medication in treatment-resistant hypertension undergoing renal denervation. J Am Heart Assoc. 2016;5:e002343.
   PubMed Web of Science ®Google Scholar
• Gundersen POM, Helland A, Spigset O, et al. Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1089:84–93.
   PubMed Web of Science ®Google Scholar
• Punt AM, Stienstra NA, van Kleef MEA, et al. Screening of cardiovascular agents in plasma with LC-MS/MS: a valuable tool for objective drug adherence assessment. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1121:103–110.
   PubMed Web of Science ®Google Scholar
• Ritscher S, Opper M, Wunder C, et al. Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy. Scientific Reports. 2019;9:15652.
   Google Scholar
• Schulz M, Iwersen-Bergmann S, Andresen H, et al. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136–134.
   PubMed Web of Science ®Google Scholar
• Repetto MR, Repetto M. Therapeutic, toxic, and lethal concentrations in human fluids of 90 drugs affecting the cardiovascular and hematopoietic systems. Clin Toxicol. 1997;35(4):345–351.
   Web of Science ®Google Scholar
• Barchielli M, Dolfini E, Farina P, et al. Clinical pharmacokinetics of lercanidipine. J Cardiovasc Pharmacol. 1997;29:S1–S15.
   PubMed Web of Science ®Google Scholar
• Kleinbloesem CH, van Harten J, van Brummelen P, et al. Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine. J Chromatogr B Biomed Sci Appl. 1984;308:209–216.
   Google Scholar
• Moen MD, Wagstaff AJ. Nebivolol: a review of its use in the management of hypertension and chronic heart failure. Drugs. 2006;66(10):1389–1409; discussion 1410.
   PubMed Web of Science ®Google Scholar
• Barbhaiya RH, Craig WA, Perri Corrick-West H, et al. Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods. J Pharm Sci. 1982;71(2):245–248.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–02):9–62. [cited 2018 Nov 21]
   PubMed Web of Science ®Google Scholar
• Kirch W, Görg KG. Clinical pharmacokinetics of atenolol–a review. Eur J Drug Metab Pharmacokinet. 1982;7(2):81–91.
   PubMed Web of Science ®Google Scholar
• Haegeli L, Brunner-La Rocca HP, Wenk M, et al. Sublingual administration of furosemide: new application of an old drug. Br J Clin Pharmacol. 2007;0(0):070917231016006–070917231016809.
   Google Scholar
• Vespasiano CFP, Laurito TL, Iwamoto RD, et al. Bioequivalence study between a fixed-dose single-pill formulation of nebivolol plus hydrochlorothiazide and separate formulations in healthy subjects using high-performance liquid chromatography coupled to tandem mass spectrometry. Biomed Chromatogr. 2017;31(5):e3884–9.
   Web of Science ®Google Scholar
• Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766–774.
   PubMed Web of Science ®Google Scholar
• Lancaster SG, Sorkin EM. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1988;36(3):256–285.
   PubMed Web of Science ®Google Scholar
• Beermann B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol. 1977;12(4):297–303.
   PubMed Web of Science ®Google Scholar
• Beermann B, Groschinsky-Grind M, Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Thera. 1976;19(5part1):531–537.
   PubMedGoogle Scholar
• Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014;100(11):855–861.
   PubMed Web of Science ®Google Scholar
• Wunder C, Persu A, Lengelé J-P, et al. Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study. Blood Press. 2019;28(3):168–172.
   PubMed Web of Science ®Google Scholar